B2B white-label manufacturer of injection-moulded plastic consumerware, exporting to 29 countries.
Price
Market Cap
Sector
Consumer Discretionary
Rank
| Line item | FY25 | FY26 | FY26 |
|---|---|---|---|
| LiabilitiesEquity Capital | 10 | 13 | 13 |
| Reserves | 238 | 581 | 600 |
| Borrowings | 223 | 133 | 86 |
| Other Liabilities | 91 | 96 | 84 |
| Total Liabilities | 562 | 823 | 784 |
| AssetsFixed Assets | 338 | 367 | 410 |
| CWIP | 22 | 39 | 42 |
| Investments | 0 | 0 | 20 |
| Other Assets | 202 | 417 | 313 |
| Total Assets | 562 | 823 | 784 |
| Line item | FY25 | FY26 |
|---|---|---|
| ActivitiesCash from Operating | 52 | 86 |
| Cash from Investing | -113 | -181 |
| Cash from Financing | 59 | 176 |
| SummaryCapital Expenditure | — | — |
| Free Cash Flow | -62 | -46 |
| FCF Margin | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (37.1×) and current (38.3×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At -25.2% growth and a 37× exit, ₹221 only delivers your return if you pay ₹18. The price is currently baking in 18% growth.
EPS grows -25.2%/yr for 5 years, then fades to 6% over 2, exits at 37×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | -25.2% | 4.32 |
| FY28 | -25.2% | 3.23 |
| FY29 | -25.2% | 2.41 |
| FY30 | -25.2% | 1.81 |
| FY31 | -25.2% | 1.35 |
| FY32 | -9.6% ·fade | 1.22 |
| FY33 | 6.0% ·fade | 1.29 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.